These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30729252)

  • 21. Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation.
    Sanderson DJ; Gevelinger M; Jaworski E; Doyle PJ
    Investig Clin Urol; 2020 Mar; 61(2):231-237. PubMed ID: 32158975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardized fluoroscopy-guided implantation technique enables optimal electrode placement in sacral neuromodulation: a cadaver study.
    Müller C; Reissig LF; Argeny S; Weninger WJ; Riss S
    Tech Coloproctol; 2021 Feb; 25(2):215-221. PubMed ID: 33211205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bullseye Technique to Optimize S3 Foramen Access: Applying a Trusted Endourology Technique to Pelvic Medicine.
    Liem SS; Demus T; Jivanji D; Palmerola R
    Urology; 2023 Jan; 171():252-254. PubMed ID: 36334773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with Sacral Neuromodulation: What Are the Factors Affecting Their Therapy Satisfaction?
    Banakhar M; Hassouna M
    Urol Int; 2019; 103(4):450-453. PubMed ID: 31574517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Landmarks for Sacral Debridement in Sacral Pressure Sores.
    Choo JH; Wilhelmi BJ
    Ann Plast Surg; 2016 Mar; 76(3):361-3. PubMed ID: 26207558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiologically anatomic measurement analysis for the third sacral foramen and an efficient implantation protocol for sacral neuromodulation.
    Huang H; Zeng W; Fan F; Li K; Xu K; Huang H
    Neurourol Urodyn; 2022 Jun; 41(5):1149-1156. PubMed ID: 35438814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor Response Matters: Optimizing Lead Placement Improves Sacral Neuromodulation Outcomes.
    Pizarro-Berdichevsky J; Gill BC; Clifton M; Okafor HT; Faris AE; Vasavada SP; Goldman HB
    J Urol; 2018 Apr; 199(4):1032-1036. PubMed ID: 29154850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder.
    Oelke M; Addali M; Reisenauer C
    Arch Gynecol Obstet; 2019 May; 299(5):1243-1252. PubMed ID: 30941558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline symptom severity and therapeutic success in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients.
    Noblett K; Berg KC; Kan F; Siegel S
    Neurourol Urodyn; 2018 Jun; 37(5):1667-1671. PubMed ID: 29635879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is a 50% improvement threshold adequate to justify progression from sacral neuromodulation testing to implant?
    Charles DK; Everett RG; Prebay ZJ; Landowski TP; O'Connor RC; Guralnick ML
    Neurourol Urodyn; 2021 Aug; 40(6):1524-1531. PubMed ID: 34005836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation.
    Starkman JS; Duffy JW; Wolter CE; Kaufman MR; Scarpero HM; Dmochowski RR
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Feb; 19(2):277-82. PubMed ID: 17671752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Is New in Neuromodulation?
    Moore CK; Rueb JJ; Derisavifard S
    Curr Urol Rep; 2019 Aug; 20(9):55. PubMed ID: 31388779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome.
    Noblett KL; Dmochowski RR; Vasavada SP; Garner AM; Liu S; Pietzsch JB
    Neurourol Urodyn; 2017 Mar; 36(3):727-733. PubMed ID: 27062384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
    Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
    J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single Institutional Experience with Single Stage Sacral Neuromodulation: Cost Savings and Outcomes in a Contemporary Case Series.
    Lee W; Artenstein D; Tenggardjaja CF; Lee UJ; Lucioni A; Reyblat P; Kobashi KC
    J Urol; 2020 Mar; 203(3):604-610. PubMed ID: 31584846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromodulation in urology, state of the art.
    Ammirati E; Giammò A; Manassero A; Carone R
    Urologia; 2019 Nov; 86(4):177-182. PubMed ID: 31368415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends and Clinical Practice Patterns of Sacral Neuromodulation for Overactive Bladder.
    Elterman DS; Chughtai B; Vertosick E; Thomas D; Eastham J; Sandhu J
    Female Pelvic Med Reconstr Surg; 2018; 24(4):264-266. PubMed ID: 28658001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sacral neuromodulation for overactive bladder in women: do age and comorbidities make a difference?
    High RA; Winkelman W; Panza J; Sanderson DJ; Yuen H; Halder G; Shaver C; Bird ET; Rogers RG; Danford JM
    Int Urogynecol J; 2021 Jan; 32(1):149-157. PubMed ID: 32588075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.